Protective HLA-B57: T cell and natural killer cell recognition in HIV infection
Open Access
- 16 September 2022
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 50 (5), 1329-1339
- https://doi.org/10.1042/bst20220244
Abstract
Understanding the basis of the immune determinants controlling disease outcome is critical to provide better care to patients and could be exploited for therapeutics and vaccine design. The discovery of the human immunodeficiency virus (HIV) virus as the causing agent of acquired immunodeficiency syndrome (AIDS) decades ago, led to a tremendous amount of research. Among the findings, it was discovered that some rare HIV+ individuals, called HIV controllers (HICs), had the ability to control the virus and keep a low viral load without the need of treatment. This ability allows HICs to delay or avoid progression to AIDS. HIV control is strongly associated with the expression of human leukocyte antigen (HLA) alleles in HICs. From the HIV protective HLAs described, HLA-B57 is the most frequent in HIC patients. HLA-B57 can present a large range of highly conserved Gag-derived HIV peptides to CD8+ T cells and natural killer (NK) cells, both the focus of this review. So far there are limited differences in the immune response strength, magnitude, or receptor repertoire towards HIV epitopes that could explain viral control in HICs. Interestingly, some studies revealed that during early infection the large breadth of the immune response towards HIV mutants in HLA-B57+ HIC patients, might in turn influence the disease outcome.Keywords
This publication has 70 references indexed in Scilit:
- The burden of HIVAIDS, 2013
- Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphismsProceedings of the National Academy of Sciences of the United States of America, 2012
- HLA Class I-Mediated Control of HIV-1 in the Japanese Population, in Which the Protective HLA-B*57 and HLA-B*27 Alleles Are AbsentJournal of Virology, 2012
- Early HLA-B*57-Restricted CD8+T Lymphocyte Responses Predict HIV-1 Disease ProgressionJournal of Virology, 2012
- Immunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionalityVirology, 2010
- Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipientsThe Journal of Experimental Medicine, 2009
- Balancing selection and heterogeneity across the classical human leukocyte antigen loci: A meta-analytic review of 497 population studiesHuman Immunology, 2008
- Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypesThe Journal of Experimental Medicine, 2007
- A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1Science, 2007
- Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutationsThe Journal of Experimental Medicine, 2006